Ainara Estanga Alustiza-rekin lankidetzan egindako argitalpenak (9)

2024

  1. GOIZ ZAINDU study: a FINGER-like multidomain lifestyle intervention feasibility randomized trial to prevent dementia in Southern Europe

    Alzheimer's Research and Therapy, Vol. 16, Núm. 1

2022

  1. Brief cognitive test as a decision tool in Primary Care settings. Population and validation study

    Neurologia

2021

  1. Plasma lipids are associated with white matter microstructural changes and axonal degeneration

    Brain Imaging and Behavior, Vol. 15, Núm. 2, pp. 1043-1057

2020

  1. Cerebrospinal Fluid 7-Ketocholesterol Level is Associated with Amyloid-β42 and White Matter Microstructure in Cognitively Healthy Adults

    Journal of Alzheimer's disease : JAD, Vol. 76, Núm. 2, pp. 643-656

2014

  1. Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2

    Parkinsonism and Related Disorders, Vol. 20, Núm. 10, pp. 1097-1100

2013

  1. Distinctive age-related temporal cortical thinning in asymptomatic granulin gene mutation carriers

    Neurobiology of Aging, Vol. 34, Núm. 5, pp. 1462-1468

2012

  1. Neuropsychological features of asymptomatic c.709-1G>A progranulin mutation carriers

    Journal of the International Neuropsychological Society, Vol. 18, Núm. 6, pp. 1086-1090

2010

  1. A Novel PRNP Y218N mutation in gerstmann-sträussler-scheinker disease with neurofibrillary degeneration

    Journal of Neuropathology and Experimental Neurology, Vol. 69, Núm. 8, pp. 789-800

2009

  1. Frontotemporoparietal dementia: Clinical phenotype associated with the c.709-1G>A PGRN mutation

    Neurology, Vol. 73, Núm. 17, pp. 1367-1374